CBV Fundamental Analysis - COBRA VENTURE CORP

Fundamental Rating

Taking everything into account, CBV scores 4 out of 10 in our fundamental rating. CBV was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. No worries on liquidiy or solvency for CBV as it has an excellent financial health rating, but there are worries on the profitability. CBV is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CBV has reported negative net income.

In the past year CBV had a positive cash flow from operations.

In multiple years CBV reported negative net income over the last 5 years.

Each year in the past 5 years CBV had a positive operating cash flow.

1.2 Ratios

CBV's Return On Assets of -4.13% is in line compared to the rest of the industry. CBV outperforms 44.65% of its industry peers.

With a Return On Equity value of -4.32%, CBV perfoms like the industry average, outperforming 47.44% of the companies in the same industry.

CBV has a Return On Invested Capital (0.20%) which is in line with its industry peers.

		Industry Rank	Sector Rank
ROA	-4.13%
ROE	-4.32%
ROIC	0.2%

ROA(3y)1.76%

ROA(5y)0.44%

ROE(3y)1.88%

ROE(5y)0.47%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CBV has a Operating Margin (0.59%) which is comparable to the rest of the industry.

CBV has a better Gross Margin (44.78%) than 69.77% of its industry peers.

CBV's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	0.59%
PM (TTM)	N/A
GM	44.78%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.24%

GM growth 5Y1.39%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CBV is destroying value.

Compared to 1 year ago, CBV has about the same amount of shares outstanding.

Compared to 5 years ago, CBV has more shares outstanding

CBV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CBV has an Altman-Z score of 11.78. This indicates that CBV is financially healthy and has little risk of bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 11.78, CBV belongs to the top of the industry, outperforming 92.09% of the companies in the same industry.

CBV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	11.78

ROIC/WACC0.02

WACC8.12%

2.3 Liquidity

CBV has a Current Ratio of 42.65. This indicates that CBV is financially healthy and has no problem in meeting its short term obligations.

CBV's Current ratio of 42.65 is amongst the best of the industry. CBV outperforms 100.00% of its industry peers.

CBV has a Quick Ratio of 42.65. This indicates that CBV is financially healthy and has no problem in meeting its short term obligations.

With an excellent Quick ratio value of 42.65, CBV belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	42.65
Quick Ratio	42.65

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CBV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -360.71%.

CBV shows a decrease in Revenue. In the last year, the revenue decreased by -1.88%.

Measured over the past years, CBV shows a decrease in Revenue. The Revenue has been decreasing by -1.48% on average per year.

EPS 1Y (TTM)-360.71%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%89.19%

Revenue 1Y (TTM)-1.88%

Revenue growth 3Y-6.83%

Revenue growth 5Y-1.48%

Sales Q2Q%27.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CBV. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CBV is valued cheaply inside the industry as 98.60% of the companies are valued more expensively.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBV is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	189.92
EV/EBITDA	0.4

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CBV!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

COBRA VENTURE CORP

TSX-V:CBV (7/8/2025, 7:00:00 PM)

0.14

+0.02 (+12%)

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners45.08%

Ins Owner ChangeN/A

Market Cap2.32M

Revenue(TTM)1.36M

Net Income(TTM)-121.70K

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.03

Dividend Growth(5Y)N/A

DP-367.3%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.7
P/FCF	189.92
P/OCF	62.62
P/B	0.82
P/tB	0.82
EV/EBITDA	0.4

EPS(TTM)-0.01

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0

FCFY0.53%

OCF(TTM)0

OCFY1.6%

SpS0.08

BVpS0.17

TBVpS0.17

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-4.13%
ROE	-4.32%
ROCE	0.28%
ROIC	0.2%
ROICexc	0.88%
ROICexgc	0.88%
OM	0.59%
PM (TTM)	N/A
GM	44.78%
FCFM	0.9%

ROA(3y)1.76%

ROA(5y)0.44%

ROE(3y)1.88%

ROE(5y)0.47%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.24%

GM growth 5Y1.39%

F-Score5

Asset Turnover0.46

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	0
Cap/Depr	14.06%
Cap/Sales	1.82%
Interest Coverage	250
Cash Conversion	20.14%
Profit Quality	N/A
Current Ratio	42.65
Quick Ratio	42.65
Altman-Z	11.78

F-Score5

WACC8.12%

ROIC/WACC0.02

Cap/Depr(3y)38.23%

Cap/Depr(5y)38.53%

Cap/Sales(3y)5.25%

Cap/Sales(5y)6.78%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-360.71%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%89.19%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-1.88%

Revenue growth 3Y-6.83%

Revenue growth 5Y-1.48%

Sales Q2Q%27.43%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y105.31%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-97.4%

FCF growth 3Y-39.04%

FCF growth 5YN/A

OCF growth 1Y-94.22%

OCF growth 3Y-35.4%

OCF growth 5Y-10.28%

COBRA VENTURE CORP / CBV.CA FAQ

Can you provide the ChartMill fundamental rating for COBRA VENTURE CORP?

ChartMill assigns a fundamental rating of 4 / 10 to CBV.CA.

What is the valuation status for CBV stock?

ChartMill assigns a valuation rating of 1 / 10 to COBRA VENTURE CORP (CBV.CA). This can be considered as Overvalued.

Can you provide the profitability details for COBRA VENTURE CORP?

COBRA VENTURE CORP (CBV.CA) has a profitability rating of 3 / 10.

Can you provide the financial health for CBV stock?

The financial health rating of COBRA VENTURE CORP (CBV.CA) is 9 / 10.

Is the dividend of COBRA VENTURE CORP sustainable?

The dividend rating of COBRA VENTURE CORP (CBV.CA) is 0 / 10 and the dividend payout ratio is -367.3%.

COBRA VENTURE CORP (CBV.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

COBRA VENTURE CORP / CBV.CA FAQ

Can you provide the ChartMill fundamental rating for COBRA VENTURE CORP?

What is the valuation status for CBV stock?

Can you provide the profitability details for COBRA VENTURE CORP?

Can you provide the financial health for CBV stock?

Is the dividend of COBRA VENTURE CORP sustainable?